Inflammation

New Evidence Links Arthritis to Increased Prostate Cancer Risk

May 15th 2025

New research suggests that adhering to an anti-inflammatory diet may lower the risk of dying from Alzheimer disease.

Prostate cancer awareness | Image Credit: ActionGP - stock.adobe.com

Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

May 9th 2025

Woman measuring man's waist with tape measure | Image Credit: fotoduets - stock.adobe.com

Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk

April 23rd 2025

"Overactive bladder" written on sticky note | Image Credit: syahrir - stock.adobe.com

Inflammatory Diets Raise Risk of Brain Disorders

April 15th 2025

Human brain illustration | Image Credit: Siarhei - stock.adobe.com

April 10th 2025

Continuing Medical Education

View All

1.5 Credits / Immunology, Allergy

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

May 20, 2025 | 1:00 PM and 8:00 PM ET

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology

1.5 Credits / Dermatology, Immunology

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

1.5 Credits / Allergy, Immunology

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

More News

February 26th 2022

Second Phase 3 Trial Shows Dupilumab Improves EoE in Patients 12 and Older

During the annual meeting of the American Academy of Allergy, Asthma and Immunology, presenters said findings from a second phase 3 trial of dupilumab for eosinophilic esophagitis (EoE) continued to show the biologic improved symptoms in adults and adolescents.

February 26th 2022

Several Postsurgery Prognostic Factors Linked With Nasal Polyp Recurrence

Polyp recurrence occurred in more than 1 in 3 patients with chronic rhinosinusitis with nasal polyps who underwent endoscopic sinus surgery, with several prognostic factors linked with recurrence.

February 25th 2022

Dupilumab Found to Significantly Improve Sense of Smell in Patients With CRS With Nasal Polyps

Patients with chronic rhinosinusitis (CRS) with nasal polyps reported significantly reduced anosmia prevalence when given dupilumab vs placebo.

February 18th 2022

Colette Romero Discusses Different Attempts at EoE Therapies

Colette Romero, an advocate for eosinophilic esophagitis (EoE) awareness, discusses the steps her family went through to find a therapy plan that worked for her son.

February 16th 2022

Asthma, Eosinophils Linked With Nasal Polyposis Recurrence

Asthma, aspirin-exacerbated respiratory disease, and nasal cytology were identified as predictors of chronic rhinosinusitis with nasal polyps recurrence.

February 12th 2022

Review Shows Evolution, Current Thinking on Managing Eosinophilic Esophagitis

Eosinophilic esophagitis is a complex disorder with significant health burdens and a recent review described how management strategies have changed over time.

February 10th 2022

Colette Romero, Advocate for EoE Awareness, Discusses Diagnosis Journey

Diagnosis delays in eosinophilic esophagitis (EoE) are common, and Colette Romero's son had symptoms soon after birth but was not diagnosed until age 3.

February 10th 2022

An Overview of Recent Advances in Management of Chronic Rhinosinusitis With Nasal Polyps

Researchers reviewed advances in the management of chronic rhinosinusitis, with and without nasal polyps, from 2020 to 2021.

February 8th 2022

Postsurgery Factors Linked With Disease Control in Chronic Rhinosinusitis With Nasal Polyps

Patients with chronic rhinosinusitis with nasal polyps who had elevated serum amyloid A (SAA) levels were more likely to achieve disease-controlled status vs those with low SAA levels after endoscopic sinus surgery.

February 5th 2022

Patients With EoE Have High Level of HCRU, Analysis Finds

This retrospective study using administrative claims data examining health care resource utilization (HCRU) found that in the months before a diagnosis of eosinophilic esophagitis (EoE), other diseases were more commonly diagnosed.

February 4th 2022

Understanding Risk Factors, Treatment of Nasal Polyps in Children

Researchers discuss contributors to nasal polyp development in children, as well as the risk of co-occuring conditions and current methods of treatment.

February 2nd 2022

Sinonasal CT Scores May Predict Prognostic Features of Chronic Rhinosinusitis With Nasal Polyps

Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.

January 28th 2022

Researchers Try to Settle Question About Possible EoE, Celiac Link

A recent study examined a possible association in children diagnosed with celiac disease and eosinophilic gastrointestinal disorders.

January 28th 2022

Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis

Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following endoscopic sinus surgery.

January 26th 2022

Mepolizumab Associated With Significant Improvement of Chronic Rhinosinusitis With Nasal Polyps, Comorbidities

Mepolizumab was found to reduce nasal polyp size and nasal obstruction in patients with chronic rhinosinusitis with nasal polyps regardless of the presence of potentially exacerbating comorbidities.

David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine

January 24th 2022

Dr David R. Stukus on Eosinophilic Esophagitis Guidelines and the Pattern of Disease

Allison Inserro Maggie L. Shaw

David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, discusses guidelines for eosinophilic esophagitis, as well as some disease patterns that may occur.

January 22nd 2022

Endoscopic Sinus Surgery With Medical Therapy Effective for Chronic Rhinosinusitis With Nasal Polyps

Patients with chronic rhinosinusitis with nasal polyps were found to benefit more from the combination of endoscopic sinus surgery plus medical therapy vs medical therapy alone, although the minimal clinically important difference was not met.

January 20th 2022

For Some Toddlers, Oral Immunotherapy Led to Remission for Peanut Allergy

For the first time, a major study showed that remission for peanut allergy can be achieved even in very young children using oral immunotherapy.

January 19th 2022

Dupilumab Linked With Significantly Improved Patient Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps

Patients with severe chronic rhinosinusitis with nasal polyps achieved significant improvements in health-related quality of life (HRQOL) and general health status with dupilumab treatment after 52 weeks.

January 15th 2022

Analysis Shows Small Rate of Eosinophilic Esophagitis in Peanut Immunotherapy Trial

AJMC Staff

The eosinophilic esophagitis responded to treatment or resolved after the peanut oral immunotherapy stopped.

January 13th 2022

Air Pollution Exposure Found to Exacerbate Severity of Chronic Rhinosinusitis With Nasal Polyps

Short-term exposure to several different types of air pollution was found to significantly increase disease severity in patients with chronic rhinosinusitis with nasal polyps.

January 10th 2022

Immunoglobulin Levels Linked With Nasal Polyp Development

Local immunoglobulin levels were found to be significantly higher in polyp tissue specimens, but not in the blood, of patients with nasal polyps.

January 8th 2022

Risk of Chronic Rhinosinusitis With Nasal Polyps Greater in Patients With Diabetes

A significant link was found regarding incidence of diabetes and chronic rhinosinusitis (CRS) with nasal polyps, whereas CRS without nasal polyps was not associated with diabetes.

January 6th 2022

Dr David R. Stukus on the Increase in Eosinophilic Esophagitis

Maggie L. Shaw

David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, talks about the increase of eosinophilic esophagitis, or EoE, along with other allergic conditions.

December 27th 2021

Top 5 Most-Read Inflammation Articles in 2021

This year's most-read inflammation articles included ones about Janus kinase inhibitors and the impact of biologics or systemic corticosteroids on severe COVID-19.

December 6th 2021

A Comparison of Administrative Claims–Based Risk Predictors for Pediatric Asthma

Annie Lintzenich Andrews, MD, MSCR Daniel L. Brinton, PhD Annie N. Simpson, PhD

A comparison of claims-based asthma risk predictors in a national sample of children with Medicaid determines accuracy and informs risk predictor choice.

December 1st 2021

Increased Weight Worsens Bronchial Patency in Children, Study Finds

The trend was true when investigators used body mass index to classify weight, and when measures such as relative body mass index and percentage of body fat were used.

November 26th 2021

Study Finds Link Between Thalassemia, Risk of Asthma

The study showed children with thalassemia had a greater risk of both atopic and non-atopic asthma.

November 15th 2021

Secondhand Smoke Leads to Respiratory Disease, Even in Adulthood

As many as 4% of population-level asthma cases could be attributed to secondhand smoke, the study suggests.

November 1st 2021

Depression Doubles Health Care Costs for Patients With Respiratory Conditions